Clinical Trial Update: Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Welichem Biotech's WBI-1001 Cream for atopic dermatitis has completed a Phase I/IIa clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• WBI-1001 Cream (WBI-1001)

Snippet

Sponsor: Welichem Biotech Inc. | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: COMPLETED